DBV Technologies S.A. - American Depositary Shares (NQ:DBVT)

23.84 -0.60 (-2.45%)

Streaming Delayed Price Updated: 3:39 PM EST, Jan 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DBV Technologies S.A. - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

DBV Technologies Shares Jumps As FDA Lifts Partial Hold On Pivotal Trial For Peanut Allergy Patch ↗

December 23, 2022

Via Benzinga

US Stocks Look To Close Volatile Week On A High — Fed's Preferred Inflation Gauge, New Home Sales Data, Tesla, AMC In Spotlight ↗

December 23, 2022

Stocks could be in for a higher opening on Friday, as indicated by the trading in the index futures. Key economic data will have a bearing on the day’s market direction, although conviction in the...

Via Benzinga

DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivotal Trial

December 23, 2022

From DBV Technologies S.A.

Via GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2022

December 08, 2022

From DBV Technologies S.A.

Via GlobeNewswire

FDA Slaps Partial Hold On DBV Technologies' Pivotal Trial Of Peanut Allergy Patch ↗

September 22, 2022

Via Benzinga

Recap: DBV Technologies Q2 Earnings ↗

August 01, 2022

DBV Technologies (NASDAQ:DBVT) reported its Q2 earnings results on Monday, August 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

DBV Technologies to Participate in Upcoming Investor Conference

November 22, 2022

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies to Highlight New Clinical Data at ACAAI 2022

November 09, 2022

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies Reports Third Quarter Financial Results and Business Update

November 03, 2022

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies to Report Third Quarter 2022 Financial Results and Provide a Business Update

October 31, 2022

From DBV Technologies S.A.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 25, 2022

Gainers DBV Technologies (NASDAQ:DBVT) stock increased by 18.7% to $1.9 during Tuesday's after-market session. The company's market cap stands at $356.7 million.

Via Benzinga

Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2022

October 20, 2022

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies Announces Appointment of New Chair of its Audit Committee and Appointment of Daniele Guyot-Caparros to Board of Directors

October 03, 2022

From DBV Technologies S.A.

Via GlobeNewswire

Algoma Steel Group, Sandstorm Gold And Some Other Big Stocks Moving Lower On Tuesday ↗

September 28, 2022

U.S. stocks traded higher, with the Dow Jones gaining around 300 points on Wednesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session ↗

September 28, 2022

Gainers

Via Benzinga

11 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 23, 2022

Gainers Rubius Therapeutics (NASDAQ:RUBY) shares moved upwards by 30.46% to $0.59. The market value of their outstanding shares is at $53.5 million.

Via Benzinga

Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday ↗

September 23, 2022

Gainers

Via Benzinga

Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session ↗

September 22, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 22, 2022

Gainers Spero Therapeutics (NASDAQ:SPRO) shares moved upwards by 122.7% to $1.83 during Thursday's pre-market session. The market value of their outstanding shares is at $64.1 million.

Via Benzinga

DBV Technologies Kickstarts Phase 3 Study Of Modified Viaskin Patch For Kids With Peanut Allergy ↗

September 08, 2022

DBV Technologies SA (NASDAQ: DBVT) initiated Phase 3 study, VITESSE, using the modified Viaskin Peanut Patch in peanut-allergic children ages 4 to 7 years.

Via Benzinga

Wayfair, American Eagle Outfitters And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

September 08, 2022

U.S. stock futures traded slightly higher this morning after recording gains in the previous session. Here are some big stocks moving lower in today’s pre-market trading session.

Via Benzinga

Why Asana Is Trading Higher By 24%; Here Are 24 Stocks Moving Premarket ↗

September 08, 2022

Gainers Asana, Inc. (NYSE: ASAN) rose 24.1% to $23.62 in pre-market trading after the company reported better-than-expected results for its second quarter and issued a strong sales guidance.

Via Benzinga

Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary ↗

September 07, 2022

Via Benzinga

Why Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day Session ↗

September 07, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 07, 2022

Via Benzinga

NIO, UiPath And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

September 07, 2022

U.S. stock futures traded slightly higher after recording losses in the previous session. Here are some big stocks moving lower in today’s pre-market trading session.

Via Benzinga

Why Coupa Software Is Trading Higher By Over 12%; Here Are 24 Stocks Moving Premarket ↗

September 07, 2022

Gainers Biophytis S.A. (NASDAQ: BPTS) shares rose 41.5% to $1.33 in pre-market trading after the company announced data on Covid treatment.

Via Benzinga

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

July 27, 2022

From DBV Technologies S.A.

Via GlobeNewswire

Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday ↗

September 06, 2022

Gainers Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The company, last month, posted downbeat quarterly results.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 06, 2022

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.